THERAZONE ApS: Financial statements 2017
CVR: 27255574
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
THERAZONE ApS (CVR 27255574) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -244,917 and a net result of DKK 43,745,998 compared with DKK 453,298 the year before. Equity in the 2017 report amounted to DKK 45,089,536. The solvency ratio was 99.9%.
- Gross Profit
- DKK -244,917
- Profit/Loss
- DKK 43,745,998
- Equity
- DKK 45,089,536
- Total Assets
- DKK 45,136,901
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -245 t. | 43.7 mio. | 45.1 mio. | - |
| 2016 | - | 238 t. | 453 t. | 1.3 mio. | - |
| 2015 | - | 25 t. | 485 t. | 890 t. | - |
| 2014 | - | 25 t. | 509 t. | 406 t. | - |
| 2013 | - | -1 t. | -234 t. | -103 t. | - |
Official annual report
Keep an eye on THERAZONE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
THERAZONE ApS has published its annual report for 2016. Gross profit came to DKK 238,343, and the net result was DKK 453,298.
About THERAZONE ApS
THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. According to the 2024 annual report, the company had an average of 2 employees. In 2024, the company reported a gross profit of DKK -255,949 and a net result of DKK 4,003,809 compared with DKK 2,462,806 the year before. Equity in the 2024 report amounted to DKK 44,842,105.